Moderate-Risk versus High-Risk RET Mutation Does Not Impact Medullary Thyroid Cancer Outcomes in MEN2A Patients

Clinical Thyroidology Sep 2017, Vol. 29, No. 9: 348-350.


http://ift.tt/2jqMp83